中文
  • About Us
    Corporate Overview Management Team Board of Directors Contact Us
  • Our Focus
    Metabolic Diseases Exploratory Indications
  • Pipeline
    Pipeline Clinical Trials
  • Partnership
  • Investors
    Financials & Filing
  • News
  • Careers
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Show More
    2014
  • Ascletis and CR Pharmaceutical Commercial Group Co., Ltd. Signed Strategic Cooperation Agreement

    2018-06-26

  • Ascletis Receives NDA Approval from China FDA for Ganovo®

    2018-06-13

  • Dr. Vivian Chen,Former VP of Eli Lilly China,Joined Ascletis as VP, Corporate Affairs

    2018-03-19

  • Ascletis Presented at J.P. Morgan Healthcare Conference

    2018-01-10

  • Populations of data propel China to the forefront of biotech

    2018-01-05

  • «
  •  
  • 1
  • 2
  •  
    • © 2018 Ascletis Pharma Inc.
    • All Rights Reserved

    contact

    • pr@ascletis.com
    • bd@ascletis.com
    • hr@ascletis.com
    • clinicaltrials@ascletis.com

    © 2018 Ascletis Pharma Inc. All Rights Reserved
    浙公网安备 33010802003344号 浙ICP备11050387号-1